Risks and benefits of dietary isoflavones for cancer
Abstract
A high intake of fruits and vegetables is associated with a lower risk of cancer. In this context, considerable attention is paid to Asian populations who consume high amounts of soy and soy-derived isoflavones, and have a lower risk for several cancer types such as breast and prostate cancers than populations in Western countries. Hence, interest focuses on soyfoods, soy products, and soy ingredients such as isoflavones with regard to their possible beneficial effects that were observed in numerous experiments and studies. The outcomes of the studies are not always conclusive, are often contradictory depending on the experimental conditions, and are, therefore, difficult to interpret. Isoflavone research revealed not only beneficial but also adverse effects, for instance, on the reproductive system. This is also the case with tumor-promoting effects on, for example, breast tissue. Isoflavone extracts and supplements are often used for the treatment of menopausal symptoms and for the prevention of age-associated conditions such as cardiovascular diseases and osteoporosis in postmenopausal women. In relation to this, questions about the effectiveness and safety of isoflavones have to be clarified. Moreover, there are concerns about the maternal consumption of isoflavones due to the development of leukemia in infants. In contrast, men may benefit from the intake of isoflavones with regard to reducing the risk of prostate cancer. Therefore, this review examines the risks but als…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Soy isoflavones show selectivity toward ER-β over ER-α.
“First, soy isoflavones show selectivity toward ER-ß over ER-α [168-175].”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [169]
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · see citing works
Messina, M., & Redmond, G. (2006) · Thyroid · doi:10.1089/thy.2006.16.249 · Cited by 200 · see citing works
D'Errico, M., Teson, M., Calcagnile, A., Nardo, T., De Luca, N., Lazzari, C., Soddu, S., Zambruno, G., Stefanini, M., & Dogliotti, E. (2005) · Cancer Research · doi:10.1158/0008-5472.432.65.2 · Cited by 64 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188 · see citing works
Does Nutrition Affect Endometriosis?
Helbig, M., Vesper, A.-S., Beyer, I., & Fehm, T. (2021) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1207-0557 · Cited by 43 · see citing works
- Authors
- Andres, S., Abraham, K., Appel, K. E., & Lampen, A.
- Affiliations
- German Federal Institute for Risk Assessment (BfR) (DE)
- Corresponding author
- Lampen, Alfonso
- ORCID
- Abraham, Klaus
- Venue
- Critical Reviews in Toxicology
- Publisher
- Informa UK Limited
- Published
- 2011-03-26
- Volume
- 41
- Issue
- 6
- Pages
- 463-506
- ISSN
- 0045-6446 (ISSN-L)
- 1040-8444
- 1547-6898
- OpenAlex
- W2126228623
- Cited by
- 168
- References
- 3
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 13 · 2016: 18 · 2015: 23 · 2014: 18 · 2013: 19 · 2012: 19
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- OpenAgrar (submittedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
- Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Keywords
- isoflavones, soy products, cancer risk, breast cancer, prostate cancer, tumor promotion, reproductive toxicity, menopausal symptoms, osteoporosis, cardiovascular disease, infant leukemia, Asian populations, dietary phytoestrogens
- MeSH terms
- Animals, Biological Availability, Carcinogens, Cardiovascular Diseases, Diet, Disease Models, Animal, Drug Combinations, Female, Humans, Isoflavones, Male, Phytotherapy, Neoplasms, Plant Extracts, Glycine max, Carcinogenicity Tests, Osteoporosis, Postmenopausal, Anticarcinogenic Agents, Risk Assessment, Hormone Replacement Therapy, Phytoestrogens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review